Matches in Nanopublications for { ?s <http://www.w3.org/2000/01/rdf-schema#label> ?o ?g. }
- licenses-with-non-commercial-clause label "licenses with a non-commercial clause" assertion.
- spi label "Licenses with a non-commercial clause generally inhibit re-use of biodiversity data." assertion.
- glycocalyx-bulk label "glycocalyx bulk" assertion.
- ecm-bound-cancer-cell label "cancer cell engaged in extracellular matrix" assertion.
- spi label "Mutations in STX1B are associated with epilepsy" assertion.
- pharmacogenomics_guided_clopidogrel_therapy label "pharmacogenomics guided clopidogrel therapy" assertion.
- spi label "Pharmacogenomics-guided clopidogrel strategy represents a cost-effective treatment for patients undergoing PCI" assertion.
- spi label "Obesity when accompanied by metabolic abnormality is closely associated with knee osteoarthritis." assertion.
- spi label "Sometimes Vitamin A targets are the same as genes associated with CAKUT" assertion.
- 0000-0002-5301-3142 label "Chris T. Evelo" assertion.
- nanopub label "add the URI of the nanopublication here" assertion.
- assertion label "Accepting or rejecting a formalization paper to the Data Science special issue 2021" assertion.
- rejected-for-publication label "rejected for publication" assertion.
- rejected-for-publication label "rejected for publication" assertion.
- rejected-for-publication label "rejected for publication" assertion.
- rejected-for-publication label "rejected for publication" assertion.
- rejected-for-publication label "rejected for publication" assertion.
- rejected-for-publication label "rejected for publication" assertion.
- accepted-for-publication label "accepted for publication" assertion.
- accepted-for-publication label "accepted for publication" assertion.
- accepted-for-publication label "accepted for publication" assertion.
- accepted-for-publication label "accepted for publication" assertion.
- accepted-for-publication label "accepted for publication" assertion.
- accepted-for-publication label "accepted for publication" assertion.
- description label "write a comment for the decision here" assertion.
- nanopub label "add the URI of the nanopublication here" assertion.
- assertion label "Accepting or rejecting a formalization paper to the Data Science special issue 2021" assertion.
- spi label "Adherence of a dataset to the FAIR Guiding Principles enables its automated discovery." assertion.
- integrin-clustering label "integrin clustering" assertion.
- spi label "Glycocalyx bulk mechanically drives integrin clustering in cancer cells engaged with the extracellular matrix" assertion.
- spi label "Sometimes Vitamin A targets are the same as genes associated with CAKUT" assertion.
- spi label "The cortex size of humans does not relate to their social group size" assertion.
- spi label "Pharmacogenomics-guided clopidogrel strategy represents a cost-effective treatment for patients undergoing PCI" assertion.
- usage-of-linked-data-scopes label "Usage of the Linked Data Scopes ontology" assertion.
- spi label "Glycocalyx bulk mechanically drives integrin clustering in cancer cells engaged with the extracellular matrix" assertion.
- spi label "When talking about biodiversity data, licenses with a non-commercial clause generally inhibit data reuse." assertion.
- triple-in-openbiodiv-knowledge-graph label "Triple in OpenBiodiv knowledge graph" assertion.
- Dysfunction_of_ERAD_pathway label "Dysfunction of ERAD pathway" assertion.
- spi label "NGLY1 deficiency is a novel autosomal recessive disorder of the ERAD pathway." assertion.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26.7 (95%CI 18.1–50.9, p < 0.05)." provenance.
- SENTENCE label "To date, only dexamethasone and remdesivir have been shown to be effective, but several other promising candidates are in trials." provenance.
- SENTENCE label "To date, only dexamethasone and remdesivir have been shown to be effective, but several other promising candidates are in trials." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.
- SENTENCE label "At present, several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir have been used because of several existing licensed drugs such as chloroquine, hydroxychloroquine, methylprednisolone, dexamethasone, and remdesivir's potential efficacy in inhibiting COVID-19." provenance.